BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23201752)

  • 1. MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma.
    Costa PM; Cardoso AL; Nóbrega C; Pereira de Almeida LF; Bruce JN; Canoll P; Pedroso de Lima MC
    Hum Mol Genet; 2013 Mar; 22(5):904-18. PubMed ID: 23201752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
    Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
    J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
    Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B
    Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput screening uncovers miRNAs enhancing glioblastoma cell susceptibility to tyrosine kinase inhibitors.
    Cunha PP; Costa PM; Morais CM; Lopes IR; Cardoso AM; Cardoso AL; Mano M; Jurado AS; Pedroso de Lima MC
    Hum Mol Genet; 2017 Nov; 26(22):4375-4387. PubMed ID: 28973155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma.
    Costa PM; Cardoso AL; Pereira de Almeida LF; Bruce JN; Canoll P; Pedroso de Lima MC
    Hum Mol Genet; 2012 Dec; 21(23):5118-30. PubMed ID: 22922228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting strategies on miRNA-21 and PDCD4 for glioblastoma.
    Wang G; Wang JJ; Tang HM; To SS
    Arch Biochem Biophys; 2015 Aug; 580():64-74. PubMed ID: 26142886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle-Delivered Antisense MicroRNA-21 Enhances the Effects of Temozolomide on Glioblastoma Cells.
    Ananta JS; Paulmurugan R; Massoud TF
    Mol Pharm; 2015 Dec; 12(12):4509-17. PubMed ID: 26559642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
    Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
    Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-873 (miRNA-873) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1.
    Wang RJ; Li JW; Bao BH; Wu HC; Du ZH; Su JL; Zhang MH; Liang HQ
    J Biol Chem; 2015 Apr; 290(14):8938-48. PubMed ID: 25670861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propolis Extract Regulates microRNA Expression in Glioblastoma and Brain Cancer Stem Cells.
    C Yilmaz U; Bagca BG; Karaca E; Durmaz A; Durmaz B; Aykut A; Kayalar H; Avci CB; Susluer SY; Pariltay E; Gunduz C; Cogulu O
    Anticancer Agents Med Chem; 2022; 22(2):378-389. PubMed ID: 33949939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of miR-96 promotes radioresistance in glioblastoma cells via targeting PDCD4.
    Guo P; Yu Y; Tian Z; Lin Y; Qiu Y; Yao W; Zhang L
    Int J Oncol; 2018 Oct; 53(4):1591-1600. PubMed ID: 30066909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy.
    Joshi AD; Loilome W; Siu IM; Tyler B; Gallia GL; Riggins GJ
    PLoS One; 2012; 7(10):e44372. PubMed ID: 23056179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-Myc negatively controls the tumor suppressor PTEN by upregulating miR-26a in glioblastoma multiforme cells.
    Guo P; Nie Q; Lan J; Ge J; Qiu Y; Mao Q
    Biochem Biophys Res Commun; 2013 Nov; 441(1):186-90. PubMed ID: 24140063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
    Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.
    Tian T; Mingyi M; Qiu X; Qiu Y
    Oncotarget; 2016 Nov; 7(48):79584-79595. PubMed ID: 27792996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of miR-21 signaling by MPS1 in human glioblastoma.
    Maachani UB; Tandle A; Shankavaram U; Kramp T; Camphausen K
    Oncotarget; 2016 Aug; 7(33):52912-52927. PubMed ID: 25991676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis.
    Smits M; Nilsson J; Mir SE; van der Stoop PM; Hulleman E; Niers JM; de Witt Hamer PC; Marquez VE; Cloos J; Krichevsky AM; Noske DP; Tannous BA; Würdinger T
    Oncotarget; 2010 Dec; 1(8):710-20. PubMed ID: 21321380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-1271 regulates glioblastoma cell proliferation and invasion by directly targeting the CAMKK2 gene.
    Huang YK; Su YF; Lieu AS; Loh JK; Li CY; Wu CH; Kuo KL; Lin CL
    Neurosci Lett; 2020 Oct; 737():135289. PubMed ID: 32791096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
    Jin L; Li H; Wang J; Lin D; Yin K; Lin L; Lin Z; Lin G; Wang H; Ying X; Wang L; Zhang Y; Teng L
    J Cell Biochem; 2019 Apr; 120(4):6188-6197. PubMed ID: 30304561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma.
    She X; Yu Z; Cui Y; Lei Q; Wang Z; Xu G; Xiang J; Wu M; Li G
    Oncol Rep; 2014 Sep; 32(3):957-64. PubMed ID: 25017996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.